by The global market for hypertension drugs is experiencing robust growth, with promising opportunities on the horizon. According to recent market research, the market size reached an estimated USD 25,135.2 million in 2021 and is projected to grow at a steady CAGR of 3.2%. Several factors are driving this upward trajectory, making it a dynamic and promising landscape for industry participants.
Expanding Activities and Growing Prevalence
One of the key drivers of the hypertension drugs market is the expanding activities of major industry players. These players are continuously innovating and introducing new disease-modifying therapies, such as angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers (CCB), which are expected to revolutionize hypertension treatment.
The global prevalence of hypertension is on the rise, primarily due to sedentary lifestyles and poor dietary habits. This alarming increase in hypertension cases has led to a surge in the demand for hypertension medications. Additionally, the introduction of generic drugs, often at more affordable prices, is expected to further drive market growth.
The Impact of COVID-19
While the COVID-19 pandemic had a disruptive impact on various industries, the hypertension drugs market showed resilience. Although there were temporary setbacks, such as slowed-down demand, supply chain disruptions, and delays in clinical studies, the market recovered steadily in 2021. Major pharmaceutical companies maintained a stable supply of medication for existing patients, minimizing the negative effects of the pandemic on sales.
Unmet Needs and Opportunities
Despite the presence of significant competitors and generic alternatives, there is a substantial unmet need for hypertension treatment. The increasing prevalence of cardiovascular diseases (CVD) worldwide has created a demand for more advanced and effective drugs. The market is ripe for innovative treatments that not only manage hypertension but also offer disease-modifying capabilities, improved efficacy, and enhanced safety.
Addressing Challenges
However, the market faces challenges, such as a lack of awareness among the public about hypertension and its treatment. In many developing countries, individuals often remain unaware of their high blood pressure until severe symptoms occur. Additionally, medication adherence remains a concern, with many patients discontinuing their treatment prematurely.
Segment Overview
Diuretics are expected to dominate the hypertension drugs market due to their proven efficacy, affordability, and minimal side effects. Thiazide diuretics, in particular, play a vital role in hypertension treatment. Hospital pharmacies are anticipated to hold the leading share of the market, driven by the aging population and the need for comprehensive diagnosis and treatment in hospital settings.
Regional Landscape
North America, especially the United States, is set to acquire the largest market share. The regions high prevalence of hypertension and advanced healthcare infrastructure are key drivers of market growth. In contrast, the Asia Pacific is expected to witness the fastest growth, driven by increasing generic drug use, proximity to pharmaceutical companies, and evolving healthcare systems.
Competitive Landscape
Prominent players in the hypertension drugs market include AstraZeneca plc, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited, Johnson & Johnson, Lupin, Novartis AG, Merck & Co., Inc, Pfizer Inc., Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), and SANOFI. These companies continue to invest in research and development to meet the growing demand for effective hypertension medications.
The global hypertension drugs market is poised for remarkable growth, driven by the pressing need to address the rising prevalence of hypertension and cardiovascular diseases. With innovative therapies and increased awareness, the industry is on track to make a significant positive impact on patients lives.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/hypertension-drugs-market
Visit Our Blogs:
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
This press release first seen on Brilad
COMTEX_442717382/2840/2023-10-31T07:38:23
Julian Lopez is professor emeritus of finance, served as the founding academic affairs dean and founding chair of the finance department.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No journalist was involved in the writing and production of this article.